| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | TESARO INCORPORATED | 10,275,113 | 1,581,032,000 | 54.99% | ||
| 2 | ARDELYX INC COM | 14,083,582 | 178,157,000 | 6.20% | ||
| 3 | ACHAOGEN INC COM | 5,215,128 | 131,578,000 | 4.58% | ||
| 4 | DERMIRA INC COM | 3,506,649 | 119,612,000 | 4.16% | ||
| 5 | EPIZYME INC COM | 6,260,851 | 107,374,000 | 3.73% | ||
| 6 | RA PHARMACEUTICALS INC COM | 3,493,636 | 74,380,000 | 2.59% | ||
| 7 | CRISPR THERAPEUTICS AG | 3,220,728 | 70,115,000 | 2.44% | ||
| 8 | ADAPTIMMUNE THERAPEUTICS PLC | 12,025,999 | 66,263,000 | 2.30% | ||
| 9 | GROUPON INC | 15,056,822 | 59,173,000 | 2.06% | ||
| 10 | SENSEONICS HOLDINGS INC | 26,305,286 | 47,086,000 | 1.64% | ||
| 11 | GLYCOMIMETICS INC | 8,584,128 | 46,612,000 | 1.62% | ||
| 12 | CARE COM INC | 3,260,989 | 40,795,000 | 1.42% | ||
| 13 | CASCADIAN THERAPEUTICS INC | 9,064,575 | 37,527,000 | 1.31% | ||
| 14 | AURINIA PHARMACEUTICALS INC | 4,808,483 | 35,294,000 | 1.23% | ||
| 15 | ObsEva SA | 3,336,563 | 34,734,000 | 1.21% | ||
| 16 | LEXICON PHARMACEUTICALS INC | 2,382,286 | 34,162,000 | 1.19% | ||
| 17 | NEVRO CORP COM | 359,678 | 33,702,000 | 1.17% | ||
| 18 | PROTEOSTASIS THERAPEUTICS IN COM | 3,556,778 | 27,814,000 | 0.97% | ||
| 19 | Strongbridge Biopharma plc | 4,141,308 | 19,671,000 | 0.68% | ||
| 20 | Aerohive Networks, Inc. | 4,309,691 | 18,144,000 | 0.63% | ||
| 21 | ENDOLOGIX INC | 2,490,204 | 18,029,000 | 0.63% | ||
| 22 | TREVENA INC | 3,811,691 | 13,989,000 | 0.49% | ||
| 23 | RIGEL PHARMACEUTICAL INC | 3,243,150 | 10,375,000 | 0.36% | ||
| 24 | Tracon Pharmaceuticals Inc | 2,759,217 | 10,347,000 | 0.36% | ||
| 25 | AVEO PHARMACEUTICALS INC | 16,362,694 | 9,654,000 | 0.34% | ||
| 26 | AFFIMED N V COM | 3,888,888 | 8,944,000 | 0.31% | ||
| 27 | Mirna Therapeutics, Inc. | 2,974,811 | 6,515,000 | 0.23% | ||
| 28 | DASAN ZHONE SOLUTIONS INC | 956,255 | 5,972,000 | 0.21% | ||
| 29 | Sunesis Pharmaceuticals, Inc. | 1,298,274 | 5,323,000 | 0.19% | ||
| 30 | AKARI THERAPEUTICS PLC | 452,167 | 5,005,000 | 0.17% | ||
| 31 | CHAMPIONS ONCOLOGY INC | 1,562,500 | 4,953,000 | 0.17% | ||
| 32 | ARCA BIOPHARMA INCORPORATED COM PAR .001 | 1,460,209 | 3,724,000 | 0.13% | ||
| 33 | ROKA BIOSCIENCE INC COM NEW | 893,471 | 3,181,000 | 0.11% | ||
| 34 | ArQule Inc | 2,520,316 | 2,672,000 | 0.09% | ||
| 35 | OREXIGEN THERAPEUTICS INC | 370,900 | 1,276,000 | 0.04% | ||
| 36 | PARATEK PHARMACEUTICALS INC | 66,245 | 1,275,000 | 0.04% | ||
| 37 | Catalyst Biosciences | 43,492 | 410,000 | 0.01% | ||
| 38 | CERECOR INC | 595,435 | 402,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001012975-17-000376, filed 2017.05.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
